Sign In
Buy BLUE
$4.97
+0 (+0%)
At Close: Aug 29, 2025
NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of bluebird bio, Inc. (NASDAQ: BLUE) between May 11, 2020 and November 4, 2020,
bluebird bio to Present at Cowen Health Care Conference
08:00am, Friday, 26'th Feb 2021
CAMBRIDGE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (NASDAQ: BLUE) today announced that members of the management team will participate in the Cowen 41st Annual Health Care Conference, Wednesday, Ma
New York, New York--(Newsfile Corp. - February 25, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of bluebird bio, Inc. (NASDAQ: BLUE) alle
New York, New York--(Newsfile Corp. - February 24, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities o
NEW YORK, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stoc
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Results from the pivotal Phase 2 KarMMa study evaluating the efficacy and safety of bluebird bio, Inc. (Nasdaq: BLUE) and Bristol Myers Squibb's (NYSE: BMY) investig
NEW YORK--(BUSINESS WIRE)--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against bluebird bio, Inc. ("bluebird" or the "Company") (NASDAQ: BLUE) and
bluebird (BLUE) Q4 Loss Narrower than Expected, Sales Miss
01:39pm, Wednesday, 24'th Feb 2021
bluebird (BLUE) reports a narrower-than-expected loss but misses sales estimates in the fourth quarter of 2020.
NEW YORK, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline for investors to file a lead plaintiff motion in a se
NEW YORK--(BUSINESS WIRE)--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against bluebird bio, Inc. ("bluebird" or the "Company") (NASDAQ: BLUE) and
BLUE ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against bluebird bio, Inc.– BLUE
10:24am, Wednesday, 24'th Feb 2021
NEW YORK, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Pawar Law Group announces a class action lawsuit on behalf of shareholders who purchased shares of bluebird bio, Inc. (NASDAQ: BLUE) from May 11, 2020 throu
New York, New York--(Newsfile Corp. - February 23, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the secur
Los Angeles, California--(Newsfile Corp. - February 23, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against bluebird bi
BENSALEM, Pa.--(BUSINESS WIRE)---- $BLUE #CLASSACTION--Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against bluebird bio, Inc. (B
New York, New York--(Newsfile Corp. - February 22, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities o
